KEGG   Muntiacus reevesi (Reeves' muntjac): 136145870
Entry
136145870         CDS       T10466                                 
Symbol
IL2
Name
(RefSeq) interleukin-2
  KO
K05429  interleukin 2
Organism
mree  Muntiacus reevesi (Reeves' muntjac)
Pathway
mree04060  Cytokine-cytokine receptor interaction
mree04061  Viral protein interaction with cytokine and cytokine receptor
mree04151  PI3K-Akt signaling pathway
mree04625  C-type lectin receptor signaling pathway
mree04630  JAK-STAT signaling pathway
mree04658  Th1 and Th2 cell differentiation
mree04659  Th17 cell differentiation
mree04660  T cell receptor signaling pathway
mree04672  Intestinal immune network for IgA production
mree04940  Type I diabetes mellitus
mree05135  Yersinia infection
mree05142  Chagas disease
mree05162  Measles
mree05166  Human T-cell leukemia virus 1 infection
mree05171  Coronavirus disease - COVID-19
mree05200  Pathways in cancer
mree05320  Autoimmune thyroid disease
mree05321  Inflammatory bowel disease
mree05330  Allograft rejection
mree05332  Graft-versus-host disease
Brite
KEGG Orthology (KO) [BR:mree00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04630 JAK-STAT signaling pathway
    136145870 (IL2)
   04151 PI3K-Akt signaling pathway
    136145870 (IL2)
  09133 Signaling molecules and interaction
   04060 Cytokine-cytokine receptor interaction
    136145870 (IL2)
   04061 Viral protein interaction with cytokine and cytokine receptor
    136145870 (IL2)
 09150 Organismal Systems
  09151 Immune system
   04625 C-type lectin receptor signaling pathway
    136145870 (IL2)
   04660 T cell receptor signaling pathway
    136145870 (IL2)
   04658 Th1 and Th2 cell differentiation
    136145870 (IL2)
   04659 Th17 cell differentiation
    136145870 (IL2)
   04672 Intestinal immune network for IgA production
    136145870 (IL2)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    136145870 (IL2)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    136145870 (IL2)
   05171 Coronavirus disease - COVID-19
    136145870 (IL2)
   05162 Measles
    136145870 (IL2)
  09171 Infectious disease: bacterial
   05135 Yersinia infection
    136145870 (IL2)
  09174 Infectious disease: parasitic
   05142 Chagas disease
    136145870 (IL2)
  09163 Immune disease
   05320 Autoimmune thyroid disease
    136145870 (IL2)
   05321 Inflammatory bowel disease
    136145870 (IL2)
   05330 Allograft rejection
    136145870 (IL2)
   05332 Graft-versus-host disease
    136145870 (IL2)
  09167 Endocrine and metabolic disease
   04940 Type I diabetes mellitus
    136145870 (IL2)
 09180 Brite Hierarchies
  09183 Protein families: signaling and cellular processes
   04052 Cytokines and neuropeptides [BR:mree04052]
    136145870 (IL2)
   00536 Glycosaminoglycan binding proteins [BR:mree00536]
    136145870 (IL2)
Cytokines and neuropeptides [BR:mree04052]
 Cytokines
  Interleukins
   136145870 (IL2)
Glycosaminoglycan binding proteins [BR:mree00536]
 Heparan sulfate / Heparin
  Cytokines
   136145870 (IL2)
SSDB
Motif
Pfam: IL2 ANAPC4 Zw10_N
Other DBs
NCBI-GeneID: 136145870
NCBI-ProteinID: XP_065760656
LinkDB
Position
13:complement(37051254..37055771)
AA seq 162 aa
MYKIQLLSCIALTLALVANGAPTSSSTGNTMKEVKSLLLDLQLLLEKVKNPENLKLSKMH
TFNFFVPKVNATELKHLNCLLEELKLLEDVLNLSPSKNLNPKEIKDSMDEIKDLMNNIKR
IVLELQESETSFKCEYDAATVKAVEFLNKWIIFCQRIYSTMT
NT seq 489 nt   +upstreamnt  +downstreamnt
atgtacaagatacaactcttgtcttgcattgcactaacacttgcactcgttgcaaacggt
gcacctacttcaagctctacggggaacacaatgaaagaagtgaagtcattgctgctggat
ttacagttgcttttggagaaagttaaaaatcccgagaacctcaagctctccaagatgcat
acatttaactttttcgtgcccaaggttaacgctacagaattgaaacaccttaactgtcta
ctagaagaactcaaacttctagaggacgtgctaaatttatctccaagcaaaaacctgaac
cccaaagagatcaaggattcaatggacgagatcaaggatttaatgaacaatatcaagaga
atagttttggaactacaggaatctgaaacaagtttcaaatgtgaatatgatgcagcgaca
gtaaaggctgtagaatttctgaacaaatggattatcttttgtcaaaggatctactcaaca
atgacttga

DBGET integrated database retrieval system